"breast tumor subtypes" trang 14 - tải miễn phí từ tailieunhanh
Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells

Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells
10    42    1
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry

Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry
7    39    1
Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer

Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
8    56    1
Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain

Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain
11    50    1
Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases

Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases
6    35    1
Eligibility criteria for intraoperative radiotherapy for breast cancer: Study employing 12,025 patients treated in two cohorts

Eligibility criteria for intraoperative radiotherapy for breast cancer: Study employing 12,025 patients treated in two cohorts
11    78    1
Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer

Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer
9    40    1
Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer

Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer
11    44    1
Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy

Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy
9    50    1
Development and validation of a clinical prediction rule to identify suspected breast cancer: A prospective cohort study

Development and validation of a clinical prediction rule to identify suspected breast cancer: A prospective cohort study
8    47    1
ERβ1: Characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

ERβ1: Characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
16    70    1
Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice

Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice
13    35    1
Oncogenic MicroRNAs: MiR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

Oncogenic MicroRNAs: MiR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
7    40    1
Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer

Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer
12    41    1
KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer

KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer
9    52    1
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer

Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer
11    76    1
PIK3R1 underexpression is an independent prognostic marker in breast cancer

PIK3R1 underexpression is an independent prognostic marker in breast cancer
15    40    1
An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain

An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain
9    42    2
Activation of SNAT1/SLC38A1 in human breast cancer: Correlation with p-Akt overexpression

Activation of SNAT1/SLC38A1 in human breast cancer: Correlation with p-Akt overexpression
9    64    1
Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
9    58    1